Dublin, Ireland (PRWEB) March 21, 2013
Research and Markets has announced the addition of Jain PharmaBiotech's new market research report "Biomarkers - Technologies, Markets and Companies - 2013 Report" to their offering.
This report describes different types of biomarkers and their discovery using various -omics technologies such as proteomics and metabolomics. Molecular diagnostics technologies are used for the discovery of biomarkers and new tests are also based on biomarker.
Biomarkers will facilitate the combination of therapeutics with diagnostics and will thus play an important role in the development of personalized medicine. Biomarkers play a role in use of pharmacogenetics, pharmacogenomics and pharmacoproteomics for development of personalized medicine.
Many of the regulatory issues concerning biomarkers are related to genomics, proteomics, molecular diagnostics and pharmacogenomics/pharmacogenetics. Validation of biomarkers and their role in clinical trials is discussed.
Biomarker markets are estimated from 2012 to 2022 according to share of markets for various technologies and applications: proteomics, metabolomics, molecular diagnostics, drug discovery, clinical trials, and bioinformatics. Market values are further split according to therapeutic applications and major geographical areas. Unfulfilled needs in biomarkers are identified as well as the drivers for biomarker markets. Challenges facing the biomarker industry and strategies for developing biomarker markets are discussed.
A large number of companies with varying technical backgrounds are involved in biomarkers and 290 of these are profiled in part 2 of the report with classification into various categories.These also include major pharmaceutical companies. There is tabulation of 551 collaborations between companies and additional academic collaborations are mentioned in the individual profiles of companies. The report is supplemented by 1,050 references, 67 tables and 16 figures.
Key Topics Covered:
2. Technologies for Discovery of Biomarkers
3. Biomarkers and Molecular Diagnostics
4. Biomarkers for Drug Discovery & Development
5. Role of Biomarkers in Healthcare
6. Biomarkers of Cancer
7. Biomarkers of Disorders of the Nervous System
8. Biomarkers of Cardiovascular Disorders
9. Biomarkers & Personalized Medicine
10. Regulatory issues
11. Markets for Biomarkers
For more information visit Biomarkers - Technologies, Markets and Companies - 2013 Report
Source: Jain PharmaBiotech
Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.